Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-08-03

Clinical Trial Update: Transauricular Vagal Nerve Stimulation; Functional Dyspepsia and Gastroparesis [NA]

View source ↗

Summary

A clinical trial evaluating transauricular vagal nerve stimulation for gastroparesis and functional dyspepsia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Transauricular vagal nerve stimulation

Snippet

Sponsor: Stanford University | Conditions: Gastroparesis, Functional Dyspepsia | NA | Status: WITHDRAWN